No doubt, 2023 has challenges for tech industries, especially the biotech industry to say the least. Continuously innovate and push products/services to the next level are the #1 priority for biotechs. Meanwhile, abundant opportunities still exist. For example, China’s reopen is a 180 move from the past 3 years. It practically unleashed a market of 1.4 b…